CoChat

HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN)

Brattstr??m, Christina, Wilczek, Henryk, Tyd??n, Gunnar, B??ttiger, Ylva, S??we, Juliette, Groth, Carl-Gustav · 1998 · Transplantation
Cited by 157

The DOI matches its Crossref record.

Abstract

BACKGROUND: Sirolimus is an interesting immunosuppressive drug that does not seem to cause nephrotoxicity, neurotoxicity, or diabetogenicity, as commonly seen in patients treated with cyclosporine or tacrolimus. In this report, we describe a possible association between sirolimus and observed hyperlipidemia. METHODS: Serum levels of triglycerides and cholesterol were analyzed in 11 patients who participated in a pilot study evaluating the effect of oral sirolimus or placebo combined with cyclosporine and corticosteroids on the occurrence of acute renal transplant rejection. RESULTS: In four of nine patients given sirolimus, significantly increased serum triglyceride levels were seen, with peak levels occurring 2-4 months after transplantation and ranging between 11.7 and 42.0 mmol/L (reference value <2.2 mmol/L). In two patients given placebo, the serum triglyceride levels remained below 5.0 mmol/L. After reduction or discontinuation of sirolimus, the serum triglyceride levels decreased within 1-2 months and after 1-8 months levels had returned to their pretransplant values. A significant increase in serum cholesterol levels was seen in one of nine patients given sirolimus. CONCLUSION: It seems that long-term treatment with sirolimus in combination with cyclosporine and corticosteroids may increase the risk of hypertriglyceridemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00007890-199805150-00023

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 157

Metadata

Authors
Brattstr??m, C., Wilczek, H., Tyd??n, G., B??ttiger, Y., S??we, J., & Groth, C.-G.
Venue
Transplantation
Published
1998-05
Volume
65
Issue
9
Pages
1272-1274
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2086589681
Cited by
157
References
0
FWCI
8.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN). https://app.cochat.ai/papers/10.1097/00007890-199805150-00023
The paper
Brattstr??m, C., Wilczek, H., Tyd??n, G., B??ttiger, Y., S??we, J., & Groth, C.-G. (1998). HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN). Transplantation. https://doi.org/10.1097/00007890-199805150-00023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.